Natco Pharma: PAT growth of 128% & Revenue growth of 62% in 9M-24 at a PE of 13
www.moneymuscle.in
NATCOPHARM guiding for 68% growth in PAT and 48% growth in revenue for FY24. Possibility of inorganic growth coming in FY26. Attractive valuations with potential for re-rating & multi-bagger returns
Natco Pharma: PAT growth of 128% & Revenue growth of 62% in 9M-24 at a PE of 13
Natco Pharma: PAT growth of 128% & Revenue…
Natco Pharma: PAT growth of 128% & Revenue growth of 62% in 9M-24 at a PE of 13
NATCOPHARM guiding for 68% growth in PAT and 48% growth in revenue for FY24. Possibility of inorganic growth coming in FY26. Attractive valuations with potential for re-rating & multi-bagger returns